5054
S. Redon et al. / Tetrahedron Letters 55 (2014) 5052–5054
J = 32.5 Hz), 128.3, 126.8, 126.2 (q, J = 3.5 Hz), 126.0, 125.4, 125.1, 123.9 (q,
J = 272.6 Hz). LC–MS (ESI+): tR = 4.77 min; m/z [M+H]+: 328.05. HRMS for
C
14H9F3NSe [M+H]+ calcd/found: 327.9847/327.9850.
2-(Furan-2-yl)-1,3-benzoselenazole (3j): White solid (65 mg), yield = 46%, mp
122–124 °C; Rf = 0.46 (ethyl acetate/petroleum ether: 10/90); 1H NMR
(200 MHz, CDCl3, d, ppm) 8.11 (d, J = 8.1, 0.6 Hz, 1H), 7.87 (d, J = 7.8, 0.8 Hz,
1H), 7.62 (d, J = 1.3 Hz, 1H), 7.49 (dd, J = 7.7, 1.2 Hz, 1H), 7.26–7.35 (m, 2), 6.61
(dd, J = 3.5, 1.8 Hz, 1H); 13C NMR (50 MHz, CDCl3, d, ppm) 160.9, 155.1, 151.0,
145.1, 137.4, 126.7, 125.4, 124.9, 124.7, 113.0, 111.4. LC–MS (ESI+):
tR = 3.07 min; m/z [M+H]+: 250.18. HRMS C11H8NOSe [M+H]+ calcd/found:
249.9766/249.9766.
2-(Thiophen-2-yl)-1,3-benzoselenazole (3k): Yellow solid (68 mg), yield = 45%,
mp 107–109 °C; Rf = 0.57 (ethyl acetate/petroleum ether: 10/90); 1H NMR
(200 MHz, CDCl3, d, ppm) 8.07 (dd, J = 8.1 Hz, 1H), 7.87 (dd, J = 7.8 Hz, 1H), 7.60
(d, J = 3.7 Hz, 1H), 7.42–7.52 (m, 2H), 7.24–7.34 (m, 1H), 7.12 (d, J = 5.1, 1.2 Hz,
1H); 13C NMR (50 MHz, CDCl3) d: 164.5, 155.1, 140.1, 137.9, 129.9, 129.8, 128.2,
126.7, 125.5, 124.8, 124.6. LC–MS (ESI+): tR = 3.50 min; m/z [M+H]+: 266.06.
HRMS C11H8NSSe [M+H]+ calcd/found: 265.9537/265.9536.
2-(1H-Pyrrol-2-yl)-1,3-benzoselenazole (3l): White solid (78 mg), yield = 55%;
mp 148–150 °C; Rf = 0.31 (ethyl acetate/petroleum ether: 10/90); 1H NMR
(200 MHz, CDCl3, d, ppm) 10.09 (s, 1H), 7.95 (d, J = 8.2 Hz, 1H), 7.91 (d, J = 8.2 Hz,
1H), 7.48 (dt, J = 6.8, 1.1 Hz, 1H), 7.20–7.25 (m, 1H), 7.00–7.05 (m, 1H), 6.80–
6.85 (m, 1H), 6.30–6.35 (m, 1H); 13C NMR (50 MHz, CDCl3, d, ppm) 163.8, 155.0,
136.7, 128.9, 126.5, 124.9, 124.7, 123.3, 122.7, 114.4, 110.9. LC–MS (ESI+):
tR = 3.02 min; m/z [M+H]+: 249.22. HRMS C11H9N2Se [M+H]+ calcd/found:
248.9926/248.9925.
5-Bromo-2-methyl-benzoselenazole (3m): White solid (70 mg), yield = 44%; mp
148–150 °C; Rf = 0.25 (ethyl acetate/petroleum ether: 10/90); 1H NMR
(200 MHz, CDCl3, d, ppm) 8.11 (d, J = 1.8 Hz, 1H), 7.70 (d, J = 8.4 Hz, 1H), 7.39
(dd, J = 8.6, 1.8 Hz, 1H), 2.87 (s, 3H); 13C NMR (50 MHz, CDCl3, d, ppm) 173.6,
155.6, 137.7, 128.0, 126.8, 125.8, 119.7, 23.8. LC–MS (ESI+): tR = 2.96 min; m/z
[M+H]+: 275.92. HRMS C8H7BrNSe [M+H]+ calcd/found: 275.8919/275.8918.
5-Methoxy-2-methyl-benzoselenazole (3n): Orange solid (25 mg), yield = 21%;
mp 88–90 °C; Rf= 0.23 (ethyl acetate/petroleum ether: 10/90); 1H NMR
(200 MHz, CDCl3, d, ppm) 7.68 (d, J = 8.5 Hz, 1H), 7.51 (d, J = 2.4 Hz, 1H), 6.92
(dd, J = 9.3, 2.1 Hz, 1H), 3.86 (s, 3H), 2.84 (s, 3H); 13C NMR (50 MHz, CDCl3, d,
ppm) 171.3, 157.0, 128.0, 123.0, 114.5, 112.6, 105.2, 53.7, 27.8. LC–MS (ESI+):
tR = 2.34 min; m/z [M+H]+: 228.19. HRMS C9H10NOSe [M+H]+ calcd/found:
227.9928/227.9923.
16. The substrates 1 were prepared from the acyl chlorides in toluene.
17. Typical experimental procedure for the synthesis of benzoselenazoles: In a 5 mL
glass vial equipped with a small magnetic stirring bar, the N-(2-iodophenyl)-
acetamide 1a (0.57 mmol, 150 mg), Woollins’ reagent (0.34 mmol, 180 mg,
1.2 equiv) were mixed with dry triethylamine (3 mL) under nitrogen
atmosphere. The vial was tightly sealed with an aluminum/teflon crimp top.
The mixture was then irradiated in a BiotageÒ Initiator microwave reactor for
3 h at 160 °C. After the reaction was complete, the reaction mixture was
evaporated under vacuum. The residue was purified by flash chromatography
on silica gel using petroleum ether/EtOAc (95:5) as the eluent, yielding 3a
(65 mg, 57%). Analysis for compounds 3a, 3e, 3f, and 3i is in agreement with
that reported in the literature.9b,c Data for the new compounds:
2-(2-Phenylethyl)-1,3-benzoselenazole (3d): White solid (87 mg), yield = 53%;
mp 114–116 °C; Rf = 0.35 (ethyl acetate/petroleum ether: 5/95); 1H NMR
(200 MHz, CDCl3, d, ppm) 7.93 (d, J = 8.2 Hz, 1H), 7.79 (d, J = 7.9 Hz, 1H), 7.38 (t,
J = 7.9 Hz, 1H), 7.12–7.27 (m, 6H), 3.39 (t, J = 7.9 Hz, 2H), 3.12 (t, J = 7.9 Hz, 2H);
13C NMR (50 MHz, CDCl3, d, ppm) 174.5, 152.0, 138.0, 136.3, 126.7, 126.6, 124.6,
124.3, 123.2, 123.0, 122.1, 37.2, 33.8. LC–MS (ESI+): tR = 4.02 min; m/z [M+H]+:
288.15. HRMS for C15H14NSe [M+H]+ calcd/found: 288.0291/288.0288.
2-(4-Chlorophenyl)-1,3-benzoselenazole (3g): White solid (82 mg), yield = 49%,
mp 101 °C; Rf = 0.35 (ethyl acetate/petroleum ether: 5/95); 1H NMR (200 MHz,
CDCl3, d, ppm) 8.12 (d, J = 8.1 Hz, 1H), 7.90–8.00 (m, 3H), 7.42–7.55 (m, 3H),
7.33 (dt, J = 7.9, 1.2 Hz, 1H); 13C NMR (50 MHz, CDCl3, d, ppm) 171.2, 155.5,
138.3, 137.3, 134.6, 129.5, 129.3, 126.7, 125.7, 125.0. HRMS for C13H9ClNSe
[M+H]+ calcd/found: 293.9581/293.9584.
2-[4-(Trifluoromethyl)phenyl]-1,3-benzoselenazole (3h): White solid (90 mg),
yield = 48%, mp 143–145 °C; Rf = 0.35 (ethyl acetate/petroleum ether: 5/95);
1H NMR (200 MHz, CDCl3, d, ppm) 8.01–8.06 (m, 3H), 7.95 (d, J = 8.0 Hz, 1H),
7.75 (d, J = 8.4 Hz, 2H), 7.37 (dt, J = 8.2 Hz, 1.2 Hz, 1H), 7.32 (dt, J = 8.0 Hz, 1.2 Hz,
1H); 13C NMR (50 MHz, CDCl3, d, ppm) 170.6, 155.7, 139.3, 138.7, 132.5 (q,